학술논문
LBA53 ELIOS: A multicentre, molecular profiling study of patients (pts) with epidermal growth factor receptor-mutated (EGFRm) advanced NSCLC treated with first-line (1L) osimertinib
Document Type
Abstract
Author
Source
In Annals of Oncology September 2022 33 Supplement 7:S1420-S1421
Subject
Language
ISSN
0923-7534